SCHEMBL7007007

SCHEMBL7007007

Cc1nc2cc(OCC(O)CN3C[CH]N(c4c(C)cccc4C)CC3)ccc2o1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.44
KMT2A Q03164 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 3/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
MAPT P10636 3/20 0.41
USP2 O75604 2/20 0.41
MAPK1 P28482 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TSHR P16473 1/20 0.41
TP53 P04637 2/20 0.41
ABCB1 P08183 2/20 0.40
ACE2 Q9BYF1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7005719 0.79 CYP3A4 (0.52) CYP3A4
SCHEMBL5227893 0.78 CYP3A4 (0.71) CYP3A4LMNATSHR
SCHEMBL28431974 0.73 KDM4E (0.62) KMT2ASMN1; SMN2MEN1KDM4EALDH1A1
SCHEMBL5222101 0.72 PRMT5 (0.42) CYP3A4KMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL7705260 0.71 PRMT5 (0.44) KMT2ASMN1; SMN2MEN1KDM4EALDH1A1
SCHEMBL7004615 0.71 LMNA (0.51) CYP3A4KMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL7708678 0.70 MAPT (0.43) KMT2ASMN1; SMN2MEN1KDM4ELMNA
SCHEMBL7705235 0.70 CYP2D6 (0.54) KMT2ASMN1; SMN2MEN1LMNAL3MBTL1
SCHEMBL7708651 0.69 CACNA1G (0.43) KMT2ASMN1; SMN2MEN1ALDH1A1LMNA
SCHEMBL5223653 0.69 HTR1A (0.40) CYP3A4SMN1; SMN2KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339701-A1 HETEROARYL ALKYL PIPERAZINE DERIVATIVES AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2003-09-03 EP claimed
WO-2002064576-A1 HETEROARYL ALKYL PIPERAZINE DERIVATIVES AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2002-08-22 WO claimed
EP-1339701-A1 HETEROARYL ALKYL PIPERAZINE DERIVATIVES AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2003-09-03 EP disclosed
WO-2002064576-A1 HETEROARYL ALKYL PIPERAZINE DERIVATIVES AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2002-08-22 WO disclosed